Cargando…

Altered innate immune profile in blood of systemic mastocytosis patients

BACKGROUND: Mast cells (MC) from systemic mastocytosis (SM) patients release MC mediators that lead to an altered microenvironment with potential consequences on innate immune cells, such as monocytes and dendritic cells (DC). Here we investigated the distribution and functional behaviour of differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez‐Pons, Alba, Jara‐Acevedo, María, Henriques, Ana, Navarro‐Navarro, Paula, García‐Montero, Andrés C., Álvarez‐Twose, Iván, Pedreira, Carlos E., Sánchez‐Muñoz, Laura, Damasceno, Daniela, Caldas, Carolina, Muñoz‐González, Javier I., Matito, Almudena, Flores‐Montero, Juan, González‐López, Oscar, Criado, Ignacio, Mayado, Andrea, Orfao, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194602/ https://www.ncbi.nlm.nih.gov/pubmed/35734269 http://dx.doi.org/10.1002/clt2.12167

Ejemplares similares

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
por: Alvarez-Twose, Iván, et al.
Publicado: (2016)

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis
por: Dasilva-Freire, Noelia, et al.
Publicado: (2019)

Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome
por: Matito, Almudena, et al.
Publicado: (2013)

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis
por: González-López, Oscar, et al.
Publicado: (2022)

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes
por: González-de-Olano, David, et al.
Publicado: (2016)

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
por: Jawhar, Mohamad, et al.
Publicado: (2019)

STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features
por: Muñoz-García, Noemí, et al.
Publicado: (2020)

Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2020)

Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
por: González-Tablas, María, et al.
Publicado: (2021)

Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression
por: Criado, Ignacio, et al.
Publicado: (2017)

Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Damasceno, Daniela, et al.
Publicado: (2021)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome
por: Criado, Ignacio, et al.
Publicado: (2018)

Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020)

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(−) mesenchymal stem cells in human bone marrow
por: Muñiz, Carmen, et al.
Publicado: (2015)

Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Intertriginous maculopapular mastocytosis in a patient with acute myeloid leukemia
por: Herrero-Moyano, María, et al.
Publicado: (2017)

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
por: Lange, Magdalena, et al.
Publicado: (2021)

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020)

Correction: Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults
por: Casabonne, Delphine, et al.
Publicado: (2013)

Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults
por: Casabonne, Delphine, et al.
Publicado: (2012)

P1023: AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM): EFFICACY AND SAFETY ANALYSES FROM THE PHASE 2 PATHFINDER STUDY WITH 2-YEAR FOLLOW-UP
por: Gotlib, Jason, et al.
Publicado: (2023)

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
por: Valent, Peter, et al.
Publicado: (2023)

Pediatric Mastocytosis: An Update
por: Giona, Fiorina
Publicado: (2021)

Cutaneous mastocytosis in childhood
por: Nemat, Katja, et al.
Publicado: (2022)

Avapritinib for Cutaneous Mastocytosis
por: LEE, Hannah, et al.
Publicado: (2021)

Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome
por: Matarraz, Sergio, et al.
Publicado: (2012)

Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice
por: Isidro-Hernández, Marta, et al.
Publicado: (2023)

Detection of Circulating Tumor Plasma Cells in Monoclonal Gammopathies: Methods, Pathogenic Role, and Clinical Implications
por: Sanoja-Flores, Luzalba, et al.
Publicado: (2020)

Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome
por: Conde-Fernandes, Iolanda, et al.
Publicado: (2017)

An elusive case of systemic mastocytosis
por: Lee, JK, et al.
Publicado: (2010)

Mastocytosis in the skin in children and adults
por: Lange, Magdalena
Publicado: (2015)

Targeted Treatment Options in Mastocytosis
por: Vaes, Mélanie, et al.
Publicado: (2017)

Systemic Mastocytosis: Multidisciplinary Approach
por: Zanotti, Roberta, et al.
Publicado: (2021)

Precision Medicine in Systemic Mastocytosis
por: Nicolosi, Maura, et al.
Publicado: (2021)

Anaesthesia in a patient with mastocytosis
por: Maheshwari, Shivi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_elao26u5hj8u25m3ajsqsmkj47